Opinion: It shouldn’t matter who the FDA commissioner is when it comes to controversial drug approval decisions
Several years ago, I interviewed for a job and the employer asked me to explain something shocking about the FDA that the general public either doesn’t know or wouldn’t understand.
I thought for a minute and said, “The FDA commissioner doesn’t weigh in on any drug approval decisions.” And the interviewer looked at me quizzically, and said something along the lines of, “That can’t be right.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,300+ biopharma pros reading Endpoints daily — and it's free.